GlassScriptPhysician profile
Margot A Crossley
NPI 1205921699
$1,438.62
in general payments reported to CMS, 2019-2025
17 companies · $167 in 2025
The $167 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $134 · 2021: $108 · 2022: $172 · 2023: $122 · 2024: $534 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $822.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $355.54 | 2022-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Supernus Pharmaceuticals, INC. | $198.58 | 2024 | Qelbree |
| Sanofi Pasteur INC. | $183.94 | 2019-2025 | |
| Cranial Technologies, INC | $148.97 | 2019-2025 | Doc Band |
| Baxter Healthcare | $88.98 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Pfizer INC. | $81.62 | 2019-2024 | |
| Ironshore Pharmaceuticals INC. | $73.49 | 2019 | |
| Glaxosmithkline, LLC. | $56.75 | 2019-2025 | Bexsero, Rotarix, Pediarix |
| Takeda Pharmaceuticals U.S.A., INC. | $50.03 | 2020-2024 | |
| Seqirus USA INC | $46.26 | 2024-2025 | Flucelvax |
| Genentech USA, INC. | $42.02 | 2019-2020 | |
| Advanced Respiratory, INC | $28.42 | 2020-2021 | |
| Corium, LLC | $24.52 | 2022 | |
| Sobi, INC | $18.63 | 2019 | |
| Oxford Immunotec USA INC | $17.49 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $12.38 | 2019 | |
| Amneal Pharmaceuticals LLC | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margot Crossley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.